Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts

Journal of Bone and Mineral Research

Volumn 19, Issue 1, 2004, Pages 89-99

  Yun, Shan Hu ^a   Zhou, Hong ^a   Myers, Damian ^b   Quinn, Julian M W ^a   Atkins, Gerald J ^c   Ly, Chi ^a   Gange, Christine ^a   Kartsogiannis, Vicky ^a   Elliott, Jan ^a   Kostakis, Panagiota ^d   Zannettino, Andrew C W ^d   Cromer, Brett ^a   Mckinstry, William J ^a   Findlay, David M ^c   Gillespie, Matthew T ^a   Kong, Wah Ng ^e  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

Bone resorption; C type lectin; Natural killer cell receptors; Natural killer gene complex; Osteoclasts

Indexed keywords

AMINO ACID; CALCITRIOL; COMPLEMENTARY DNA; DEXAMETHASONE; INTERLEUKIN 1ALPHA; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOCLAST INHIBITORY LECTIN; OSTEOPROTEGERIN; PROSTAGLANDIN E2; PROTEIN INHIBITOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL ISOLATION; CHROMOSOME 12; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA LIBRARY; DRUG INHIBITION; GENE LOCATION; GENE STRUCTURE; GENETIC CONSERVATION; GENOME ANALYSIS; HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PREDICTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN ISOLATION; SARCOMA CELL; STRUCTURAL HOMOLOGY; UPREGULATION;

EID: 24744463719     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.0301215     Document Type: Article

References (33)

1. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
2. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
3. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
4. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
5. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
6. Martin TJ, Romas E, Gillespie MT 1998 Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8:107-123.
7. Zhou H, Kartsogiannis V, Hu YS, Elliott J, Quinn JM, McKinstry WJ, Gillespie MT, Ng KW 2001 A novel osteoblast-derived c-type lectin that inhibits osteoclast formation. J Biol Chem 276:14916-14923.
8. Zhou H, Kartsogiannis V, Quinn JM, Ly C, Gange C, Elliott J, Ng KW, Gillespie MT 2002 Osteoclast inhibitory lectin, a family of new osteoclast inhibitors. J Biol Chem 277:48808-48815.
9. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ 1999 Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14:47-56.
10. Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM 2001 Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 28:370-377.
11. Quinn JM, Morfis M, Lam MH, Elliott J, Kartsogiannis V, Williams ED, Gillespie MT, Martin TJ, Sexton PM 1999 Calcitonin receptor antibodies in the identification of osteoclasts. Bone 25:1-8.
12. Hodge JM, Kirkland MA, Aitken CJ, Myers DE, Nicholson GC 2002 Osteoclastic potential of human cord blood mononuclear cells and derived CFU-GM: Effects of M-CSF, GM-CSF and IL-3. J Bone Miner Res 12:S455.
13. Heydemann A, Boehmler JH, Simon MC 1997 Expression of two myeloid cell-specific genes requires the novel transcription factor, c-fes expression factor. J Biol Chem 272:29527-29537.
14. Boles KS, Barten R, Kumaresan PR, Trowsdale J, Mathew PA 1999 Cloning of a new lectin-like receptor expressed on human NK cells. Immunogenetics 50:1-7.
15. Yabe T, McSherry C, Bach FH, Fisch P, Schall RP, Sondel PM, Houchins JP 1993 A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 37:455-460.
16. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM 1997 The natural killer gene complex: A genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 155:53-65.
17. Yokoyama WM, Seaman WE 1993 The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Annu Rev Immunol 11:613-635.
18. Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR 1993 Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol 23:1643-1648.
19. Lopez-Cabrera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sanchez-Mateos P, Sanchez-Madrid F 1993 Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 178:537-547.
20. Hamann J, Fiebig H, Strauss M 1993 Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J Immunol 150:4920-4927.
21. Weis WI, Kahn R, Fourme R, Drickamer K, Hendrickson WA 1991 Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science 254:1608-1615.
22. Wong S, Freeman JD, Kelleher C, Mager D, Takei F 1991 Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. J Immunol 147:1417-1423.
23. Weis WI, Taylor ME, Drickamer K 1998 The C-type lectin superfamily in the immune system. Immunol Rev 163:19-34.
24. Houchins JP, Yabe T, McSherry C, Bach FH 1991 DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 173:1017-1020.
25. Plougastel B, Dubbelde C, Yokoyama WM 2001 Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69. Immunogenetics 53:209-214.
26. Plougastel B, Matsumoto K, Dubbelde C, Yokoyama WM 2001 Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: Cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics 53:592-598.
27. Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO 1997 A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 7:615-618.
28. Testi R, D'Ambrosio D, De Maria R, Santoni A 1994 The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15:479-483.
29. Lanier LL 1998 NK cell receptors. Annu Rev Immunol 16:359-393.
30. Hamann J, Montgomery KT, Lau S, Kucherlapati R, van Lier RA 1997 AICL: A new activation-induced antigen encoded by the human NK gene complex. Immunogenetics 45:295-300.
31. Lauzurica P, Sancho D, Torres M, Albella B, Marazuela M, Merino T, Eueren JA, Martinez AC, Sanchez-Madrid F 2000 Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 95:2312-2320.
32. James IE, Dodds RA, Lee-Rykaczewski E, Eichman CF, Connor JR, Hart TK, Maleeff BE, Lackman RD, Gowen M 1996 Purification and characterization of fully functional human osteoclast precursors. J Bone Miner Res 11:1608-1618.
33. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ, Gillespie MT 1999 Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25:525-534.